New Mexico health officials: Measles case reported in San Juan County
The child, who had received one dose of the measles, mumps and rubella vaccine, contracted the virus on a domestic flight.
The new case comes about a week and a half after officials said exposures were possible at sites in Santa Fe, although no local cases have been reported.
The best way to avoid measles is to get the MMR vaccine, health officials say. The first shot is recommended for children between 12 and 15 months old and the second between 4 and 6 years old.
'Travel can increase the risk of exposure,' Dr. Miranda Durham, chief medical officer at the Department of Health, said in a statement Tuesday. 'Whether you're traveling within the U.S. or abroad, before you go make sure you're up to date on your vaccines.'
The diagnosis brings New Mexico's total measles cases to 81 amid a series of outbreaks of the disease nationwide. Though New Mexico's measles cases stem from a larger outbreak in West Texas, more than 1,000 cases had been reported across 32 states, data from the Centers for Disease Control and Prevention show.
San Juan County is the seventh New Mexico county to see a measles case since February and the first in the far northern reaches of the state. The majority of cases remain in Lea County, with six more in Sandoval County, three in Eddy County, two in Doña Ana County and one each in Chaves and Curry counties.
The Navajo Nation, which includes much of San Juan County, issued health advisories in February and March warning residents of the dangers of measles.
Though the child caught measles outside of San Juan County, the Department of Health warned people might have been exposed to measles recently at the following locations:
* San Juan Regional Medical Center Emergency Room, 801 W. Maple St. in Farmington, from 10:30 p.m. May 26 to 4:15 a.m. May 27 and from 2 to 4 p.m. May 28.
* San Juan Regional Medical Center Health Partners Pediatrics Clinic, 407 S. Schwartz, Suite 102 in Farmington, from 8:15 to 10:30 a.m. May 30.
* NorLea Hobbs Medical Clinic, 1923 N. Dal Paso St in Hobbs, from 8:45 to 11:30 a.m. May 27.
Measles symptoms, which develop seven to 21 days after exposure, include fever, cough, runny nose and red eyes, followed by a red, spotted rash that usually starts on the head or face and spreads down the body.
The state Department of Health advises people who develop symptoms to stay home to prevent further spread and contact their health care providers or the agency's Helpline at 833-SWNURSE (833-796-8773) for further guidance.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Measles cases in US over 4.5 times higher than all of last year
Measles cases in the United States are continuing to rise after breaking a decades-long record just two weeks ago. There are now 1,319 confirmed measles cases across 39 states, according to data from the Centers for Disease Control and Prevention (CDC) updated Wednesday. This is the highest nationwide measles figure seen since 1992. National cases are more than 4.5 times higher than the entirety of last year, which had an estimated 285 cases reported. MORE: Amid growing Texas outbreak, how contagious is measles? So far, two children and one adult have died from the virus this year, the first deaths from measles in a decade. About one to three of every 1,000 children infected with measles die from respiratory and neurologic complications, according to the CDC. An overwhelming majority of this year's cases -- 92% -- are among those who were unvaccinated or whose vaccination status is unknown, CDC data shows. Measles was declared eliminated from the U.S. in 2000 due to a highly effective vaccination program, according to the CDC Childhood vaccination rates to protect against measles have been declining in recent years, CDC data shows. The rate of kindergarteners receiving state-required vaccinations dropped from 95% in the 2019-2020 school year to less than 93% in the 2023-2024 school year, according to CDC data. A 95% threshold is the ideal level to protect for herd immunity, public health experts note. This leaves about 280,000 U.S. kindergarteners, or 7.3%, without protection from the virus. MORE: Amid growing Texas outbreak, how contagious is measles? A measles vaccine became available in 1963. Prior to that, nearly all children got measles by the time they were 15 years old. It led to an estimated 500 deaths and 48,000 hospitalizations each year before the shot was widely available, according to the CDC. Children in the U.S. are recommended to receive the two-dose measles, mumps, and rubella (MMR) vaccine with the first dose at 12 to 15 months of age and the second between 4 and 6 years old. One dose is 93% effective, and two doses are 97% effective, the CDC says. A booster shot is not typically recommended for adults who already have immunity from the virus through vaccination or prior infection.
Yahoo
5 hours ago
- Yahoo
Trade bodies welcome Ireland alcohol health warning labels delay
The local and European drinks trade has reacted positively to Ireland's delay of implementing health warnings and calorie information on alcoholic beverages. Reports emerged last week indicating the government's intention to delay putting the legislation into force. Two senior government officials told Politico the move was being made due to fears of US tariffs affecting Ireland's drinks exports. In a statement to Just Drinks yesterday (23 July), the Department of Health said: "Following the Government's decision to defer the implementation of alcohol labelling requirements from 2026 to 2028, the Department of Health will arrange for the necessary amendments to the relevant regulations." National drinks trade body Drinks Ireland welcomed the delay. It said the move brings "much-needed relief" for producers, "and allows our exporters to focus their resources and efforts on market diversification and indeed, survival of their businesses". The Irish drinks sector is already facing "major trade uncertainty, new tariffs on product[s] entering our most important export market, the US, and threats of further tariff escalation", the association said, adding while Irish producers are focused on exports, they also require a "strong, competitive domestic marketplace". The country passed the legislation in 2023. It required alcohol producers to include health warning labels on drinks labelling information for alcoholic beverages. The labels were intended to highlight the risks of drinking alcohol and include information on a product's calorie content. They were supposed to come into effect from May next year. The labelling law which was to be implemented "as a unilateral national measure" would have seen packaging and labelling costs go up "by some 35%", according to Drinks Ireland. The trade body argued that the law should be implemented at the EU level "to maintain the integrity of the EU Single Market and avoid additional costs on Irish businesses versus our competitors". "Pushing through this unilateral change would have resulted in some businesses forgoing the Irish market, would have driven up the price of doing business for all drinks producers and would have impacted on the cost and choice for consumers." EU wine trade body Comité Européen des Entreprises Vins (CEEV) also welcomed the Irish government's decision, describing it as "an important opportunity to re-align regulatory efforts with EU law and the principles of the Single Market". 'Introducing a unilateral and disproportionate health warning on all alcoholic beverages sold in Ireland would have imposed significant costs and administrative burdens, especially for small and medium-sized wine producers, while undermining the integrity of the EU Single Market and legal framework," said Marzia Varvaglione, president of the CEEV. "Public health objectives must be pursued in a legally sound and coordinated way. Fragmentation only leads to confusion for consumers and unnecessary costs for producers,' she added. The CEEV filed a complaint to the European Commission on Ireland's new labelling laws when they were announced two years ago, it said, stating that the legislation went against "the Union's legal framework". 'This pause shall be more than just a delay, it is a much-needed chance to rethink how we ensure consumers are well-informed, while also safeguarding the legal and economic coherence of the European market,' Ignacio Sánchez Recarte, the secretary general of CEEV, said. 'Wine producers and consumers deserve rules that are balanced, evidence-based, and applied consistently across the EU.' Delay with "real-life consequences", says charity Local charity Alcohol Action Ireland however said it was "disappointed" by the delay, arguing that the legislation was a crucial part of Ireland's Public Health (Alcohol) Act (2018), which looks to reduce the negative effects of alcohol, and cut down national consumption. Dr Sheila Gilheany, the CEO of Alcohol Action Ireland, said: 'To say that this delay is a blow for public health in Ireland is an understatement. It is a failure of leadership and of democracy. "It's not just that Irish people are being denied their right to information regarding some of the facts about alcohol so that they can make informed decisions. It's not just that the government is allowing its own groundbreaking legislation to be undermined by the very industry it is designed to regulate. "This delay will have real-life consequences that will be felt by ordinary Irish people every day." "Trade bodies welcome Ireland alcohol health warning labels delay" was originally created and published by Just Drinks, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Medscape
a day ago
- Medscape
After a Long Delay, ME/CFS Strategy Finally Arrives
The Department of Health and Social Care has published its long-delayed delivery plan to improve care and support for people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The plan was welcomed by Action for ME as 'an important step towards recognising the scale and seriousness of the condition', but the charity warned it 'simply does not go far enough'. ME/CFS affects around 390,000 people in the UK. Symptoms include debilitating fatigue, sleep problems, and difficulties with thinking, concentration, and memory. Around one in four people diagnosed with the condition report being housebound or unable to work. Focus on Three Priority Areas The cross-government plan was developed in consultation with the NHS and external stakeholders. It focuses on three priorities: Research Attitudes and education Living with ME/CFS A consultation on the interim plan, launched in July 2023, revealed widespread dissatisfaction with how people with ME/CFS are treated. Respondents reported difficulties accessing specialist services, negative attitudes from professionals, and challenges relating to education, welfare, and employment, including benefits. Delays Sparked Criticism In February this year, Liberal Democrat health spokesperson Helen Morgan told The Times the plan represented an 'opportunity to move away from this legacy of neglect towards a transformation of care and research'. However, she noted that it had taken 33 months and five health secretaries to get to this point. When the final plan was still unpublished last month, Morgan described the further delay as 'inexcusable'. People with ME and their carers had been 'left behind for decades', she said. 'They have faced inadequate care, scant research funding, no treatments, and little hope of a better future.' Government Acknowledges Patient Concerns In the plan's foreword, Minister for Public Health and Prevention Ashley Dalton acknowledged the inconsistency of care and the feeling among some patients that their condition had not been appropriately recognised by the health and care system. 'I know that those with severe or very severe ME/CFS, and their families and carers, have often felt particularly let down by those systems,' she said. In a separate letter to members of the ME/CFS Task and Finish Group on the day of the final plan's launch, Dalton acknowledged: 'People living with ME/CFS often face stigma and misunderstanding,' which she attributed to 'a lack of awareness and education about the condition.' The final plan includes a commitment to introduce new training for NHS healthcare professionals 'as a priority' to address stigma and improve professional understanding. Access to Services and Employment Support The government said that ME/CFS patients would benefit from closer-to-home care under neighbourhood health services, as outlined in its 10-year health plan. It also promised support through reforms to benefit assessment processes and employment initiatives for people with long-term conditions and disabilities. However, Action for ME said these proposals lacked detail and failed to show how they would bring about 'meaningful change'. Research Funding Still Limited The plan includes increased funding for ME/CFS research via the National Institute for Health and Care Research and the Medical Research Council. This includes exploring the repurposing of existing medicines for ME/CFS. However, Action for ME warned that competitive grant processes were 'unlikely to reverse the long history of underfunding of ME research'. Other conditions, such as dementia, mental health, and rare diseases benefit from dedicated platforms with sustained, multi-million-pound funding, it said. Calls for Strategic Commitment Action for ME also criticised the government for ignoring its calls for strategic research funding and a dedicated ME research hub. Chief Executive Sonya Chowdhury said the plan was an 'important step for the ME community, long overlooked and under-served'. However, she added 'the plan must not be a token gesture – it requires a sustained, strategic commitment to care, funding, and research'. In her foreword, Dalton said future funding would depend on what is 'practically feasible and financially viable and affordable, especially within the challenging current fiscal climate'.
